Search Results - "Pocock, Stuart"

Extension Reports in Clinical Trials: A Systematic Review and Consequent Guidance.

Authors: Rossello, Xavier Pocock, Stuart J. Taylor, Dylan et al.

Source: Journal of the American College of Cardiology (JACC). Apr2026, Vol. 87 Issue 15, p1873-1888. 16p.

β blockers after myocardial infarction with mildly reduced ejection fraction: an individual patient data meta-analysis of randomised controlled trials.

Authors: Rossello, Xavier Prescott, Eva Irene Bossano Kristensen, Anna Meta Dyrvig et al.

Source: Lancet. Sep2025, Vol. 406 Issue 10508, p1128-1137. 10p.

Subjects: Myocardial infarction, Adrenergic beta blockers, Ventricular ejection fraction, Heart failure, Medical record databases, Randomized controlled trials, Treatment effectiveness

The win ratio method in heart failure trials: lessons learnt from EMPULSE.

Authors: Pocock, Stuart J. Ferreira, João Pedro Collier, Timothy J. et al.

Source: European Journal of Heart Failure. May2023, Vol. 25 Issue 5, p632-641. 10p. 2 Diagrams, 3 Charts, 1 Graph.

Biomarker‐driven prognostic models in chronic heart failure with preserved ejection fraction: the EMPEROR–Preserved trial.

Authors: Pocock, Stuart J. Ferreira, João Pedro Packer, Milton et al.

Source: European Journal of Heart Failure. Oct2022, Vol. 24 Issue 10, p1869-1878. 10p. 2 Charts, 5 Graphs.

Competing Risks in Clinical Trials: Do They Matter and How Should We Account for Them?

Authors: Gregson, John Pocock, Stuart J. Anker, Stefan D. et al.

Source: Journal of the American College of Cardiology (JACC). Sep2024, Vol. 84 Issue 11, p1025-1037. 13p.

Reporting Extended Follow-Up in Cardiovascular Clinical Trials.

Authors: Gaudino, Mario Pocock, Stuart Rockhold, Frank et al.

Source: Journal of the American College of Cardiology (JACC). Dec2023, Vol. 82 Issue 23, p2246-2250. 5p.

Determinants of Progression and Regression of Subclinical Atherosclerosis Over 6 Years.

Authors: Mendieta, Guiomar Pocock, Stuart Mass, Virginia et al.

Source: Journal of the American College of Cardiology (JACC). Nov2023, Vol. 82 Issue 22, p2069-2083. 15p.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Impact of Antihypertensive Medication Changes After Renal Denervation Among Different Patient Groups: SPYRAL HTN-ON MED.

Authors: Townsend, Raymond R. Ferdinand, Keith C. Kandzari, David E. et al.

Source: Hypertension (0194911X). May2024, Vol. 81 Issue 5, p1095-1105.

Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial.

Authors: Mahfoud, Felix Kandzari, David E Kario, Kazuomi et al.

Source: Lancet. 4/9/2022, Vol. 399 Issue 10333, p1401-1410. 10p.

A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry.

Authors: Mehran, Roxana Owen, Ruth Chiarito, Mauro et al.

Source: Lancet. 11/27/2021, Vol. 398 Issue 10315, p1974-1983. 10p.

Subjects: Acute kidney failure, Ventricular ejection fraction, Percutaneous coronary intervention, Symptoms, Congestive heart failure, Logistic regression analysis

Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved.

Authors: Rogers, Jennifer K. Pocock, Stuart J. McMurray, John J.V. et al.

Source: European Journal of Heart Failure. Jan2014, Vol. 16 Issue 1, p33-40. 8p.

How to interpret figures in reports of clinical trials.

Authors: Pocock, Stuart J. Travison, Thomas G. Wruck, Lisa M.

Source: Clinical Otolaryngology. Aug2008, Vol. 33 Issue 4, p354-358. 5p. 4 Diagrams, 4 Graphs.

Figures in clinical trial reports: current practice & scope for improvement.

Authors: Pocock, Stuart J. Travison, Thomas G. Wruck, Lisa M.

Source: Trials. 2007, Vol. 8, p36-52. 17p.

Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA.

Authors: Poulter, Neil R. Wedel, Hans Dahlöf, Björn et al.

Source: Lancet. 9/10/2005, Vol. 366 Issue 9489, p907-913. 7p. 4 Charts, 2 Graphs.

Subjects: Blood pressure, Therapeutics, Hypertension, Antihypertensive agents, Cerebrovascular disease risk factors, Coronary heart disease risk factors, Cardiovascular diseases risk factors, Cardiovascular pharmacology, Research methodology

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme.

Authors: Pfeffer MA Swedberg K Granger CB et al.

Source: Lancet. 9/6/2003, Vol. 362 Issue 9386, p759-766. 8p.

The pros and cons of noninferiority trials.

Authors: Pocock, Stuart J.¹

Source: Fundamental & Clinical Pharmacology. Aug2003, Vol. 17 Issue 4, p483-490. 8p.